Table 4.
Variables | Univariable analysis |
Multivariable analysis |
||||
---|---|---|---|---|---|---|
β | 95% CI | P-value | β | 95% CI | P-value | |
Age (years) | 0.47 | 0.34 to 0.61 | <0.001 | 0.28 | 0.15 to 0.42 | 0.003 |
Sex (female) | −0.70 | −4.32 to 2.92 | 0.704 | |||
Diabetes mellitus | 3.16 | −1.58 to 7.90 | 0.191 | |||
Arterial hypertension | 2.50 | −1.15 to 6.15 | 0.179 | |||
Previous myocardial infarction | 9.87 | 4.59 to 15.15 | <0.001 | 4.36 | −0.63 to 9.34 | 0.087 |
Dyslipidaemia | −0.36 | −4.46 to 3.75 | 0.865 | |||
History of atrial fibrillation | 2.05 | −3.78 to 7.88 | 0.490 | |||
Beta-blockers | 2.15 | −1.63 to 5.93 | 0.265 | |||
RAAS-inhibitors | 2.08 | −1.66 to 5.82 | 0.275 | |||
Calcium blockers | 2.93 | −1.50 to 7.36 | 0.195 | |||
Diuretics | 6.26 | 2.27 to 10.24 | 0.002 | 3.65 | −0.03 to 7.262 | 0.058 |
Statins | 4.12 | 0.39 to 7.85 | 0.031 | 2.42 | −0.96 to 5.80 | 0.160 |
LVEF (%) | −0.77 | −0.93 to −0.61 | <0.001 | −0.24 | −0.44 to −0.04 | 0.020 |
LV mass index (g/m2) | 0.25 | 0.20 to 0.29 | <0.001 | 0.20 | 0.15 to 0.26 | <0.001 |
Aortic valve area (cm2) | −19.12 | −23.20 to −15.04 | <0.001 | −8.55 | −13.39 to −3.72 | 0.001 |
Stroke volume index (mL/m2) | −0.35 | −0.49 to −0.19 | <0.001 | −0.03 | −0.19 to 0.13 | 0.734 |
QRS-duration (per 10 ms) | 3.24 | 2.35 to 4.14 | <0.001 | 1.12 | 0.25 to 1.99 | 0.012 |
Bold are those with a P<0.05 (significant).
CI, confidence interval; EF, ejection fraction; LV, left ventricular; RAAS, renin–angiotensin–aldosterone system.